EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Basal Activation of Type I Interferons (Alpha2 and Beta) and 2 ′ 5 ′ OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis

Danilo Bretas de Oliveira, Gabriel Magno de Freitas Almeida, Antônio Carlos Martins Guedes, Flávia Patrícia Sena Teixeira Santos, Claudio Antônio Bonjardim, Paulo César Peregrino Ferreira, Erna Geessien Kroon

International Journal of Rheumatology · 2011 · 2011 · 1-6

DOI: 10.1155/2011/275617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatology, 2011. Verfasst von Danilo Bretas de Oliveira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Vírus, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenue Antônio Carlos 6627, Pampulha 31270-901 Belo Hor…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo a Pesquisa do Estado de Minas Gerais.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Systemic sclerosis (SSc) is a complex autoimmune disease in which interferons (IFNs) may play an essential role. We hypothesized that type I and III IFNs may be found in increased levels in patients and be responsible for SSc autoimmune status.

Methods

Type I and III IFN and ISG basal expression profiles were measured by qPCR using RNA from PBMCs of patients and controls .

Results

Type I IFNs are increased in SSc patients, while no induction of type III IFNs was detected. This induction cannot be related to IRF7, since no upregulation of this gene was seen on patients. Of the ISGs tested, 2 ′ 5 ′ OAS levels were increased in patients, while 6–16 and MxA levels were not.

Conclusions

While there is no indication of type III IFN induction, increased levels of type I IFNs may lead to abnormal regulation of ISGs that can be responsible for immune system alterations described for SSc.

Autor:innen und Institutionen

  • Laboratório de Vírus, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Avenue Antônio Carlos 6627, Pampulha 31270-901 Belo Horizonte, MG, Brazil.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo a Pesquisa do Estado de Minas Gerais

Zitieren

APA

de Oliveira, D. B., Almeida, G. M., Guedes, A. C., Santos, F. P., Bonjardim, C. A., Ferreira, P. C., & Kroon, E. G. (2011). Basal Activation of Type I Interferons (Alpha2 and Beta) and 2 ′ 5 ′ OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis. International Journal of Rheumatology, 2011, 1-6. https://doi.org/10.1155/2011/275617

Vancouver

de Oliveira DB, Almeida GM, Guedes AC, Santos FP, Bonjardim CA, Ferreira PC, et al. Basal Activation of Type I Interferons (Alpha2 and Beta) and 2 ′ 5 ′ OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis. International Journal of Rheumatology. 2011;2011:1-6. doi:10.1155/2011/275617

BibTeX
@article{deOliveira2011,
  author = {de Oliveira, Danilo Bretas and Almeida, Gabriel Magno de Freitas and Guedes, Antônio Carlos Martins and Santos, Flávia Patrícia Sena Teixeira and Bonjardim, Claudio Antônio and Ferreira, Paulo César Peregrino and Kroon, Erna Geessien},
  title = {Basal Activation of Type I Interferons (Alpha2 and Beta) and 2 ′ 5 ′ OAS Genes: Insights into Differential Expression Profiles of Interferon System Components in Systemic Sclerosis},
  journal = {International Journal of Rheumatology},
  year = {2011},
  volume = {2011},
  pages = {1--6},
  doi = {10.1155/2011/275617}
}
Kostenlos starten →